Allo-SCT using BU, CY and melphalan for children with AML in second CR-Reference-Cited by-同舟云学术

Allo-SCT using BU, CY and melphalan for children with AML in second CR

Published:2012-10-29 Issue:5 Volume:48 Page:651-656
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Beier R,Albert M H,Bader P,Borkhardt A,Creutzig U,Eyrich M,Ehlert K,Gruhn B,Greil J,Handgretinger R,Holter W,Klingebiel T,Kremens B,Lang P,Mauz-Körholz C,Meisel R,Müller I,Peters C,Reinhardt D,Sedlacek P,Schulz A,Schuster F R,Schrauder A,Strahm B,Sykora K W,Wössmann W,Zimmermann M,Sauer M G

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2012204.pdf

Reference26 articles.

1. Klusmann JH, Reinhardt D, Zimmermann M, Kremens B, Vormoor J, Dworzak M et al. The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study. Haematologica 2012; 97: 21–29.

2. Burnett AK, Wheatley K, Goldstone AH, Stevens RF, Hann IM, Rees JH et al. The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Haematol 2002; 118: 385–400.

3. Wells RJ, Adams MT, Alonzo TA, Arceci RJ, Buckley J, Buxton AB et al. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children’s Cancer Group Study 2951. J Clin Oncol 2003; 21: 2940–2947.

4. Aladjidi N, Auvrignon A, Leblanc T, Perel Y, Benard A, Bordigoni P et al. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology. J Clin Oncol 2003; 21: 4377–4385.

5. Abrahamsson J, Clausen N, Gustafsson G, Hovi L, Jonmundsson G, Zeller B et al. Improved outcome after relapse in children with acute myeloid leukaemia. Br J Haematol 2007; 136: 229–236.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing transplantation procedures through identification of prognostic factors in second remission for children with acute myeloid leukemia with no prior history of transplant;Haematologica;2023-07-20

2. Allogeneic hematopoietic stem cell transplant in pediatric acute myeloid leukemia: Lessons learnt from a tertiary care center in India;Pediatric Transplantation;2020-11-03

3. Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients;Clinical Pharmacokinetics;2020-10-30

4. Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies;Bone Marrow Transplantation;2020-03-20

5. Acute toxicity and outcome among pediatric allogeneic hematopoietic transplant patients conditioned with treosulfan-based regimens;Pediatric Hematology and Oncology;2020-03-13